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Summary Immunohistochemical localization of chondroitin sulphate and dermatan sulphate proteoglycans
(PGs) was observed in 70 tumour tissues, using monoclonal antibodies 9A-2 and 3B-3 raised against core
molecules obtained from chondroitin sulphate PG by chondroitinase ABC-treatment. They recognize a stub
of ADi-4S and ADi-6S binding to core protein via a linkage tetrasaccharide, respectively. The antibody 6B6
raised against dermatan sulphate PG obtained from an ovarian fibroma capsule in our laboratory was also
used. The interstitial fibrous elements, so-called 'specific stroma' within the cancer cell nests contained
chondroitin 4-sulphate PG as revealed with 9A-2, whereas the surrounding connective tissue and the pre-
existing fibrous connective tissue involved in the tumour growth consisted of dermatan sulphate PG with a
considerable amount of chondroitin 4-sulphate PG. Chondroitin 6-sulphate PG as revealed with 3B-3 was
located in the connective tissue proliferating from blood vessels and muscle tissue in association with the
invasive growth of tumour cells. Chondroitin 6-sulphate PG was also observed in the basement membrane
components of some tumours. In non-epithelial tumours (fibrogenic, chondrogenic, osteogenic and neurogenic
tumours), chondroitin 4-sulphate was in fibrous portions. When collagenization and hyalinization progressed,
dermatan sulphate PG was observed to increase in quantity.
Chondroitin sulphate isomers are widely distributed in
animal tissues as connective tissue or cell membrane
components (lozzo, 1985; Hewitt & Martin, 1984).
Chondroitin 4-sulphate, chondroitin 6-sulphate and
dermatan sulphate are the most well-known and abundant
components. Dermatan sulphate was found to have an
intimate relation to collagen fibre formation (Scott &
Orford, 1981), and keratan sulphate PG and chondroitin
sulphate PG have been shown to bind to specific sites on the
collagen fibril (Scott & Haigh, 1985a, b; 1986), but the
function and significance of each chondroitin sulphate
isomer remains unclear.
A marked production of connective tissue is a well
recognized phenomenon in a variety of invasive tumours.
Connective tissues within cancer cell nests are induced from
normal host tissues under the influence of tumour-derived
factors, such as tumour growth factor, tumour angiogenic
factor, and stimulating factor of glycosaminoglycan synthesis
or collagen synthesis (Folkman & Haudenschild, 1980; Bano
et al., 1983; lozzo, 1985; Ignotz & Massague, 1986), though
some connective tissue proliferation is recognized as result of
non-specific repair processes. Although the molecular
mechanisms by which the induction of connective tissue is
regulated are virtually unknown, changes of extracellular
matrix components might be able to influence and facilitate
the proliferation, infiltration and metastatic properties of the
tumour cells. Chondroitin sulphate and hyaluronic acid in
various tumour tissues are in much higher concentration
than in non-neoplastic tissues (Takeuchi et al., 1976; Dietrich
et al., 1977; lozzo et al., 1982a,b; Sobue et al., 1987), and we
proposed a potential role for chondroitin sulphate as a
growth regulator in neoplasia (Takeuchi, 1965). lozzo (1984)
concluded that connective tissue rich in sulphated PG is a
major determinant of the growth and infiltrative capacity of
malignant cells.
Recently, the monoclonal antibodies 9A-2 and 3B-3 were
produced against a stub of ADi-4S and ADi-6S unit binding
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to a core protein via a linkage tetrasaccharide obtained from
chondroitin sulphate PG by chondroitinase ABC-treatment,
respectively (Couchman et al., 1984a; Caterson et al., 1985).
Using these antibodies, these authors demonstrated immuno-
histochemically a specific and distinctive distribution of
chondroitin 4- or 6-sulphate PG in different connective tissue
types; viz. chondroitin 6-sulphate distributions as revealed by
the antibody 3B-3 after chondroitinase ABC pretreatment of
tissue sections were observed not only in cartilage but also in
the intima and media of aorta as well as basement
membrane components, whereas chondroitin 4-sulphate as
revealed by the antibody 9A-2 was found to be widely
distributed in loose connective tissues of the normal rat.
Recently, we obtained a monoclonal antibody against intact
PG from the capsule of a human ovarian fibroma by a
standard hybridoma technique in our laboratory. This
antibody, designated 6B6, reacts specifically with the core
molecules of dermatan sulphate PG (antigen). By staining
with these antibodies, the localization of chondroitin
sulphate and dermatan sulphate PG in tissue sections was
achieved. In the present study, in order to clarify the major
alterations of sulphated PG in tumour tissues, the
identification of chondroitin sulphate PG and dermatan
sulphate PG was studied by immunohistochemical
techniques, using the antibodies (9A-2, 3B-3 and 6B6), on 70
surgically excised specimens. It was found that the
distribution of PGs was different in the interstitial fibrous
element of tumour tissues and normal tissues.
Materials and methods
Antibodies
Monoclonal antibodies used in the present study were: 9A-2
(against a stub of ADi-4S unit binding to core protein
obtained from chondroitin sulphate PG by chondroitinase
ABC) and 3B-3 (against a stub of ADi-6S unit binding to
core protein obtained from chondroitin sulphate PG by
chondroitinase ABC) (Couchman et al., 1984a,b) and the
gifts of Seikagaku Kogyo Company Ltd., Tokyo. Antibodies
against dermatan sulphate PG, which was purified from the
capsular tissue of a human ovarian fibroma (Sobue et al.,
1987), were produced by the conventional hybridoma
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technique in our laboratory. One of the monoclonal
antibodies, IgGI, designated 6B6, was found to react
specifically with the intact molecule of the antigen (dermatan
sulphate PG) and the chondroitinase AC-treated core
molecule on Western blotted nitrocellulose membrane.
Chondroitinase ABC and chondroitinase AC were
purchased from Seikagaku Kogyo Co., Ltd., Tokyo.
Tumour tissues
The tumour tissues examined, which originated in our
hospital, were: 33 carcinomas (6 adenocarcinomas of the
stomach, 5 adenocarcinomas of the colon, 5 ductal
carcinomas of the breast, 7 adenocarcinomas of the ovary, 4
endometrial carcinomas, 2 squamous cell carcinomas of the
uterine cervix and 4 thyroid carcinomas), 1 malignant
melanoma, 1 malignant poroma, 1 seminoma, 5 adenoid
cystic carcinomas of the salivary gland, 5 fibroadenomas of
the breast, and 24 non-epithelial tumours (5 leiomyomas, 8
neurogenic tumours, 2 chondrogenic tumours, 2 osteo-
sarcomas, 3 malignant fibrous histiocytomas, I angioma
and I liposarcoma and 2 hamartomas of the lung). Human
normal tissues were also studied from 4 autopsy cases.
Immediately after excision, tissue slices 5 mm thick were
cut from the excised tissues and fixed in glacial acetic acid
I % (v/v) in 95% ethanol (Sainte-Marie, 1962) at 4°C for
12-24h. The specimens were dehydrated in an ethanol series
of ascending concentrations and embedded in paraffin wax.
Sections were 4,m.
Immunohistochemical detection ofchondroitin sulphate PG and
dermatan sulphate PG
The staining methods for 9A-2 and 3B-3 were as follows:
Deparaffinized sections were soaked in methanol containing
0.3% (v/v) H202, and then washed with PBS, followed by
treatment with chondroitinase ABC. Digestion was done
with 0.2Uml- 1 of the enzyme in 20mM Tris-HCI buffer
pH8.0 containing 20mM acetic acid and protease inhibitors
(10mM EDTA, 10mM phenylmethylsulfonylfluoride and
0.035mM pepstatin, the same cocktail as described by Oike
et al., 1980). The reactions were performed at 37°C for 1 h.
Enzyme-treated sections were allowed to react with normal
goat serum (1:100 dilution), followed by reaction with the
diluted mouse ascites (1:1000-2000) containing monoclonal
antibody. After 1 h reaction of monoclonal antibody at room
temperature, excess antibody was removed by washing with
PBS. The bound antibodies were labelled with biotinylated
anti-mouse immunoglobulin and peroxidase conjugated
streptavidin (StrAviGen B-SA immunostaining kits,
BioGENEX Lab. Dublin, Ca., USA). After washing again
with PBS, tissue sections were soaked in 0.05 M sodium
acetate-acetic acid buffer pH5.0 containing 0.02% (w/v) 3-
amino 9-ethylcarbazol and 0.014% (w/v) H202, and allowed
to react for 5-10min. Sections were counterstained with
haematoxylin and embedded in gelatin solution. As controls,
chondroitinase ABC-untreated tissue sections were employed.
The staining method for 6B6 was the same as that for 9A-2
and 3B-3. For 6B6-staining, chondroitinase ABC treatment
was not essential, but a small increase in intensity of positive
reaction was observed in the treated sections. In the present
study, the tissue sections were generally pretreated with
chondroitinase ABC.
Results
The localization of the substance revealed with each
monoclonal antibody (9A-2, 3B-3 or 6B6) was compared
among 70 tumour tissues and some normal tissues. The
interstitial elements of all normal tissues were positive with
6B6 directed against the intact small dermatan sulphate PG:
Dermis, submucosal layer of digestive canals, perichondral
layer, perivascular connective tissue, adventitia of aorta,
vascular endothelium, pleura, fibrous capsule of kidney and
liver, endo- and peri-neurium of nerve sheath. Aortic wall
and cartilage were not reactive with 6B6. The results suggest
that antibody 6B6 reacts specifically with small dermatan
sulphate PG-IT, which was designated by Rosenberg et al.
(1985). The epitope of the antibody 9A-2 is a stub of ADi-4S
unit remaining on a core molecule of chondroitin sulphate
PG and dermatan sulphate PG after chondroitinase ABC-
treatment. Therefore, the reactive sites for the 6B6 were
almost coincident with those for 9A-2 in normal interstitial
tissues, except for cartilage and aorta. The epitope of
antibody 3B-3 is a stub of ADi-6S unit remaining on a core
molecule of chondroitin sulphate PG after chondroitinase
ABC digestion. Antibody 3B-3 reacted with blood vessels,
cartilage and basement membrane of some ductal cells. The
sites reactive with 3B-3 were not coincident with those
reactive either with 6B6 or 9A-2 in normal or neoplastic
tissues.
Epithelial tumours
In most carcinoma tissues examined in the present study, the
interstitial fibrous element, the so-called 'specific stroma' in
cancer cell nests was observed to be intensely positive with
antibody 9A-2, but it was negative or only weakly stained
with 3B-3 and 6B6, as shown in Figures 1 & 2. The pre-
existing connective tissue involved in the tumour growth and
the fibrous tissue surrounding the cancer cell nests or
capsules were positive with both 9A-2 and 6B6. These results
indicated that the interstitial fibrous tissue of carcinoma is
composed mainly of chondroitin 4-sulphate, whereas the
supporting connective tissues and capsules contained PG
consisting mainly of dermatan sulphate. With 3B-3, the
intensely positive reaction was observed in the vessel walls,
perivascular fibrous tissues and muscle tissues when they
were invaded by carcinoma cells. Figure 3 shows that the
blood vessels and perivascular connective tissue within
carcinoma (cervical cancer) tissue was strongly positive with
3B-3. As shown in Figure 4, the connective tissue in
association with gastric carcinoma cells in submucosa was
positive with 3B-3, and the muscularis mucosae in the vicinity
of the cancer cell nests was thickened and positive with 3B-3.
These results may indicate that chondroitin 6-sulphate PG is
synthesized by young connective tissues and muscle tissues
when their proliferation is stimulated by adjacent tumour
growth.
In the cases of adenoid cystic carcinoma, a unique staining
pattern was observed (Figure 5a, b). The mucoid materials in
the pseudocystic spaces were intensely stained with 3B-3 but
not with 9A-2. On the contrary, the outer stromal areas were
intensely reactive with 9A-2, but not 3B-3. Supporting
connective tissue and capsule were positive with 6B6. The
inner surface of pseudocyst and the intercellular material of
the tumour cells were positive with the 3B-3. The interface
between the tumour cell nests and the outer stromal areas
were occasionally reactive for the 3B-3. As the pseudocystic
spaces were replaced by hyalinized fibrous tissue, reactivity
with 9A-2 could be observed while that with 3B-3
diminished.
In the cases of malignant poroma, malignant melanoma
and seminoma, the thin fibrous tissues observed as the
interstitial component in the tumour tissues were clearly
positive with 9A-2, but not with 6B6 or 3B-3.
The myxomatous areas of intracanalicular fibroadenoma
of the breast were stained only with 3B-3, while pericanal-
icular fibrous connective tissue was reactive with 9A-2 and
6B6. The basement membrane of ductal cells was
occasionally positive with 3B-3 in cases of fibroadenoma and
breast cancer(ductal carcinoma).
Non-epithelial tumours
In contrast to the epithelial tumours, positive reactions with
3B-3 were observed in the intercellular matrices in almost all
F5a 5b
6 2 -e,,j_..<*!Ke,o...+iis
F*FIm<gS2eS
:r .' Ji * t S
jjjlErti v ! 1i *00; 6 t t Ut m9N;iFbit,t..*.*,,*.,tS,ffit=>A@;ci;hS.|||.
.X xt i 4>,, ws, _ '. <
3
4 8
Figure 1 Immunostaining with antibody 9A-2 in endometrial carcinoma. The interstitial fibrous element is intensely positive.
(Counterstained with haematoxylin, x 75). Figure 2 Immunostaining with antibody 6B6 in the same section as Figure 1. The
interstitial fibrous element is very weakly positive. (Counterstained with haematoxylin, x 75). Figure 3 Immunostaining with
antibody 3B-3 in squamous cell carcinoma of the uterine cervix. Intensely positive reaction is seen in the stromal element of
vessel wall and the perivascular fibrous tissues within cancer cell nest. (Counterstained with haematoxylin,
x 75). Figure 4 Immunostaining with antibody 3B-3 in gastric cancer. Proliferating connective tissue in association with the
invasive growth of carcinoma cells is positive. The positive reaction is also seen in the thickened muscularis mucosae in the vicinity
of the cancer cell nests and in the stromal element of blood vessel. (Counterstained with haematoxylin, x 15).
Figure 5 Immunostaining with antibodies 313-3 (a) and 9A-2 (b) in adenoid cystic carcinoma. The 3B-3 positive reaction is seen
in the mucoid substance in the pseudocystic spaces, and occasionally in the interface between outer stromal area and cancer
cell nests (a). The 9A-2 positive reaction is seen in the outer stromal areas (b). (Counterstained with haematoxylin,
x 30). Figure 6 Immunostaining with antibody 3B-3 in malignant fibrous histiocytoma of the bone (femur). The stromal
element is observed to be positive. (Counterstained with haematoxylin, x 75). Figure 7 Immunostaining with antibody 3B-3 in
osteosarcoma. The stromal element of chondroid areas is strongly positive. (Counterstained with haematoxylin, x 75).
Figure 8 Immunostaining with antibody 6B6 in the same section as Figure 7. The hyalinous collagen and osteoid are positive.
(Counterstained with haematoxylin, x75).
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cases (fibrogenic, myogenic, chondrogenic and osteogenic
tumours). Figure 6 shows that 3B-3 positive reaction in an
area showing a storiform pattern of malignant fibrous
histiocytoma. In general, the portions where collagenization
became marked were positive with 9A-2, and when the
fibrous components became hyalinized, the reaction with
both 9A-2 and 6B6 was intense.
Chondroid tissues, both benign and malignant, were
strongly positive with 3B-3. In a case of osteosarcoma, a
typical cartilage formation was observed in association with
deposition of hyalinized collagen and osteoid. Figures 7 & 8
show that the neoplastic cartilage was strongly positive with
3B-3 in contrast to the intensely positive reaction with 6B-6
in hyalinized collagen and osteoid. In a hamartoma
occurring in the lung, chondromatous tissue and loose
connective tissue consisting of immature mesenchymal cells
were positive with 3B-3.
Discussion
Antibodies 9A-2 and 3B-3 react with the 4- and 6-sulphated
disaccharide units, respectively, which are generated from the
chondroitin sulphate chains by digestion with chondroitinase
ABC. The antibodies do not recognize the entire
constituency of the chondroitin sulphate-repeating units.
Chondroitinase ABC, which is an endo-eliminase, can
degrade the chondroitin sulphate chain so as to leave only
one disaccharide unit attached to the linkage tetrasaccharide
(Oike et al., 1980). The antibodies probably react to the
disaccharide units bound intimately to the linkage
tetrasaccharides. Couchman et al. (1984a,b) showed that in
addition to chondroitin 4-sulphate, dermatan sulphate was
also stained with 9A-2 in rat cartilage, dermis and loose
connective tissue after chondroitinase ABC digestion.
It has been reported that the amount of glycosamino-
glycan in tumour tissues is much larger than in non-
neoplastic tissues (Kojima et al., 1975; Dietrich et al., 1977;
Takeuchi et al., 1976; Sobue et al., 1980b; Sobue et al., 1987;
lozzo et al., 1982a,b). Recently, we demonstrated that the
glycosaminoglycan-synthetic activity of tumour tissues was
markedly higher than that of non-neoplastic tissues in
human gastric mucosa and adipose tissues (Sobue et al.,
1980a, b). We also demonstrated that leiomyosarcoma
contains a large amount of large PG with chondroitin
sulphate side chains and small PG having dermatan
sulphate-chondroitin sulphate side chains (Sobue et al.,
1987). The core molecule of the small PG from leiomyo-
sarcoma was quite similar in molecular weight to those from
benign tumours (leiomyoma, ovarian fibroma and
Schwannoma). The small PGs from the benign tumours are
considered to be of the same PG family as those from non-
neoplastic tissues such as skin (Damle et al., 1982), uterine
cervix (Uldbjerg et al., 1983), bone (Franzen & Heinegard,
1984), tendon (Vogel & Heinegard, 1985), cartilage
(Rosenberg et al., 1986) and other tissues. Antibody 6B6 was
also found to react with the core molecules obtained from
the small PG of benign non-epithelial tumours as described
in a previous paper (Sobue et al., 1987). The present results
showed that the interstitial fibrous element of carcinoma was
positive with 9A-2, but negative or very weakly positive with
6B6. This presumably indicates that the interstitial fibrous
element of carcinoma tissue is composed mainly of
chondroitin 4-sulphate PG with only a little, if any,
dermatan sulphate PG. It is conceivable that the interstitial
elements of carcinoma tissues contain PG having the core
molecule other than the small PG revealed with 6B6 or a
core molecule modified at the epitope site of reactivity with
6B6, though the PG in the surrounding connective tissue is
of the same small PG family as described above.
It has been observed that cultured myogenic cells or
embryonic myogenic tissues produce high buoyant density
PGs carrying predominantly chondroitin 6-sulphate side
chains (Carrino & Caplan, 1982; 1984). Recently, Hollman et
al. (1986) found that proliferating arterial smooth muscle
cells produce PG, consisting mainly of chondroitin 6-
sulphate, at a higher rate than non-dividing cells. Wight et
al. (1985) demonstrated that smooth muscle cells increase
sulphated PG synthesis - 3-4 fold when stimulated to
proliferate. In the present study, a markedly positive reaction
for antibody 3B-3 was observed in the stromal element of
blood vessels proliferating within or near the carcinoma cell
nests. The connective tissues growing from the muscle layer,
muscularis mucosae and vessel walls in association with the
infiltrative growth of carcinoma cells were also intensely
positive with 3B-3. These results suggest that the PG
carrying chondroitin 6-sulphate is synthesized by the
myogenic cells which are proliferating in association with
tumour growth. It is conceivable that the growing tumour
cells stimulate the proliferation of connective tissue cells
from muscle tissue whose chondroitin 6-sulphate synthetic
activity is markedly enhanced. Since it has been reported
that transforming growth factor or connective tissue
activating peptide (platelet derived growth factor) stimulate
synthesis of extra-cellular matrix components (Castor et al.,
1983; Ignotz & Massague, 1986), it is conceivable that these
factors act on chondroitin 6-sulphate-synthesis and on
proliferating connective tissue in association with tumour
growth.
The present result also indicated that adenoid cystic
carcinoma cells produce PG consisting mainly of chondroitin
6-sulphate which accumulated in the pseudocystic spaces,
being replaced by chondroitin 4-sulphate if hyalinization
progressed. Toida et al. (1985) reported that the pseudocysts
of adenoid cystic carcinoma represent a peculiar structure
consisting of basement membrane components. Couchman et
al. (1984a), using antibody 3B-3, demonstrated a striking
specificity of staining in basement membrane zones. They
had confirmed lack of cross-reactivity of the 3B-3 antibody
with other basement membrane components (laminin, type
IV collagen and heparan sulphate PG) by antigen absorption
of ELISA assays. On the other hand, it is well known that
myoepithelial cells contribute to the formation of the unique
structure of adenoid cystic carcinoma (Hubner et al., 1971;
Hoshino & Yamamoto, 1970). Therefore, the present results
seemed to show that the appearance of chondroitin 6-
sulphate in adenoid cystic carcinoma had an intimate
relationship with the proliferation of myoepithelial cells
which are able to form a large amount of the basement
membrane components.
In the present study, 3B-3-positive reactivity was also
observed in matrix-rich connective tissues, such as the
myxomatous areas of intracanalicular fibroadenoma of the
breast, the loose connective tissue in lung hamartoma and
the myxoid areas of non-epithelial tumours, whereas 9A-2-
positivity was observed in the fibrous connective tissue and
when collagenization progressed the reactivity with both 9A-
2 and 6B6 was observed to be more intense. It was
conceivable that the presence of chondroitin 6-sulphate has
an antifibrotic action, whereas chondroitin 4-sulphate has a
close connection with collagenization of fibrous connective
tissue.
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